CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Truong, H. H.
Right arrow Articles by Bergeron, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Truong, H. H.
Right arrow Articles by Bergeron, L.
Canadian Journal of Anesthesia 48:470-473 (2001)
© Canadian Anesthesiologists' Society, 2001

Regional Anesthesia and Pain

Spinal anesthesia: a comparison of procaine and lidocaine

Hong Hanh Le Truong, MD, Michel Girard, MD MHPE FRCPC, Pierre Drolet, MD FRCPC, Yvan Grenier, MD FRCPC, Carl Boucher, MD and Lyne Bergeron, MD

From the Département d'anesthésie-réanimation, Hôpital Maisonneuve-Rosemont and Université de Montréal, Montréal, Québec, Canada.

Address correspondence to: Dr. Michel Girard, Département d'anesthésie-réanimation, Hôpital Maisonneuve- Rosemont, 5415 boul. L'Assomption, Montréal, Québec, H1T 2M4, Canada. Phone: 514-252-3426; Fax: 514-252-3542; E-mail: girardmi{at}videotron.ca


    Abstract
 TOP
 Abstract
 Methods
 Results
 Discussion
 Conclusion
 References
 
Purpose: To compare spinal procaine to spinal lidocaine with regard to their main clinical characteristics and incidence of transient radicular irritation (TRI).

Methods: In this randomized, double-blind, prospective study, patients (two groups, n=30 each) received either 100 mg of lidocaine 5% in 7.5% glucose (Group L) or 100 mg of procaine 10% diluted with 1 ml cerebrospinal fluid (Group P). After spinal anesthesia, segmental level of sensory block was assessed by pinprick. Blood pressure and the height of the block were noted each minute for the first ten minutes, then every three minutes for the next 35 min and finally every five minutes until regression of the block to L4. Motor blockade was evaluated using the Bromage scale. To evaluate the presence of TRI, each patient was questioned 48 hr after surgery.

Results: Time to highest sensory level and to maximum number of segments blocked showed no difference between groups. Mean time for sensory regression to T10 and for regression of the motor block were shorter in Group P. Eighty minutes following injection, sensory levels were lower in Group P. Five patients had inadequate surgical anesthesia in Group P and only one in Group L. No patient in Group P had TRI (95% CI 0–12 %) while eight (27%) in Group L did (95% CI 12–46%).

Conclusions: Procaine 10% was associated with a clinical failure rate of 14.2%. This characteristic must be balanced against an absence of TRI, which occurs more frequently with the use of lidocaine 5%.

FOR the last 50 yr, lidocaine has been the local anesthetic of choice for short procedures under spinal anesthesia. Recently, it has been associated with transient radicular irritation (TRI)1,2 which makes its use less and less acceptable.3 Therefore, alternatives to lidocaine are needed. Procaine, which also has a short duration of action,4 could be an alternative to lidocaine.

This randomized, double-blind, prospective study compares the clinical characteristics of procaine to those of lidocaine during spinal anesthesia and the incidence of TRI associated with both medications.


    Methods
 TOP
 Abstract
 Methods
 Results
 Discussion
 Conclusion
 References
 
After approval of the study by our institutional Ethics Committee, patients gave informed, written consent. We studied 66 patients, ASA I and II, scheduled for surgery (<60 min) under spinal anesthesia. Patients were excluded if they were allergic to local anesthetics or p-aminobenzoic acid (PABA) or complained of back pain. Patients were randomized to receive 100 mg hyperbaric 5% lidocaine (Group L) or 100 mg of procaine 10% diluted with 1 ml CSF (Group P). If needed, patients received midazolam 1 mg iv before anesthesia. Prior to spinal anesthesia, patients received a bolus of Lactated Ringer's solution 10 ml•kg–1. After routine installation of monitors (Datex AS/3), a baseline blood pressure was taken. Dural puncture was performed in the sitting position, midline at L3–4, with a 27-gauge Whitacre needle. The anesthetic was injected within ten seconds with the bevel of the needle oriented in a cephalic direction and the end of the injection was used as T0. In the supine position, the segmental level of sensory block was assessed by pinprick on the left side. A blinded observer noted blood pressure and the height of the block each minute for the first ten minutes, then every three minutes for the next 35 min and, finally, every five minutes until regression to L4. Ephedrine (5–10 mg) was administered if the systolic pressure fell by more than 20% of the baseline value or below 90 mmHg. Motor blockade was assessed (Bromage scale) upon arrival in the recovery room and every five minutes thereafter. Failure of spinal anesthesia was defined as a sensory level insufficient to perform surgery or a surgery that outlasted duration of sensory blockade. Meperidine (5–15 mg) was used if analgesia was insufficient and metoclopramide (10 mg) was given for nausea.

TRI was defined as pain in the legs or back, of moderate or severe intensity (pain score >3/10),5 appearing after resolution of anesthesia and lasting more than 24 hr. To evaluate the presence of TRI, a blinded observer contacted the patients 48 hr after surgery. A comprehensive symptom checklist was used. Patients reporting symptoms rated the degree of discomfort using a 10-point verbal scale (0=no pain to 10=worst conceivable pain). Analgesic intake was recorded. Care was taken to differentiate TRI from other sources of pain.

The results are expressed as mean ± standard deviation. A P <0.05 was considered significant. To compare demographic data, maximum number of blocked segments, time to reach the highest segment, delay for regression to T10 and maximum decrease of the blood pressure, T test for unpaired value, Fisher's exact test, chi-square test or Mann-Whitney U test were used when appropriate. Multiple comparisons between groups were made with either repeated-measures ANOVA (blood pressure) or Mann-Whitney U test with Bonferroni's correction (number of blocked segments). Sensory and motor block regression were analysed with Kaplan-Meier curves and compared with a log-rank.

Considering a difference of 20 min for the regression of sensory blockade to T10 between groups to be clinically relevant, this study exhibits a power of 80% and an alpha error of 0.05.


    Results
 TOP
 Abstract
 Methods
 Results
 Discussion
 Conclusion
 References
 
There was no difference between groups for demographics, duration and type of surgery or patient positioning (Table IGo). Time to highest sensory level and maximum number of segments blocked were not different. Mean times for sensory regression to T10 and regression of motor blockade were shorter in Group P (Table IIGo). Residual motor block was greater in Group L (Figure 1Go). After 80 min, sensory levels were lower in Group P (Figure 2Go).


View this table:
[in this window]
[in a new window]
 
TABLE I Demographic data, midazolam dose and type of surgery
 

View this table:
[in this window]
[in a new window]
 
TABLE II Characteristics of blocks
 


View larger version (19K):
[in this window]
[in a new window]
 
FIGURE 1 Recovery from motor block, Kaplan-Meier curves, log-rank test, P <0.0005.

 


View larger version (47K):
[in this window]
[in a new window]
 
FIGURE 2 Sensory level as a function of time, Mann-Whitney U test for each interval with Bonferroni correction for multiple comparisons, median, *P <0.05.

 
Doses of midazolam (Table IGo) are similar. The doses of ephedrine administered and systolic blood pressures for each interval showed no difference. The use of metoclopramide was equivalent in each group (Group P: n=3, Group L: n=1). Two patients in each group received meperidine iv in the postanesthesia care unit. Intake of oral medication, at home, was not different.

Five patients had inadequate surgical anesthesia in Group P (four due to insufficient sensory level, one due to insufficient duration of block) and one in Group L. All required general anesthesia and were excluded from the final data analysis. No patient in Group P had TRI (95% CI 0–12 %), while eight (27%) in Group L did (95% CI 12–46%).


    Discussion
 TOP
 Abstract
 Methods
 Results
 Discussion
 Conclusion
 References
 
Procaine could be adequate for short duration surgery. However, the high failure rate observed in the present study, although inconsistent with our own previous experience,4 might dismiss its use, unless additives can improve this.

A dose of 100 mg of each local anesthetic was chosen. This dose is considered the maximum safe dose for procaine, while lidocaine 100 mg has been widely investigated and used clinically. For lidocaine, neither the reduction of the dose,5 nor of its concentration,7,8 appears to modify the incidence of TRI. It could be argued that the doses used are not equipotent, the lidocaine/procaine potency ratio being described classically as 2/1. However, little data exist to document this ratio.9

The only study6 comparing the incidence of TRI between procaine and lidocaine showed results similar (lidocaine: 31%, procaine: 6%) to ours. The same dose of procaine (100 mg) was used, while that of lidocaine was 50 mg to respect the alleged potency ratio mentioned earlier. The failure rate with procaine (17%) was similar to ours (14%). Similarly, patients receiving procaine had a greater tendency to be nauseated (17%) than those receiving lidocaine (3%) as in our work (procaine: 10%, lidocaine: 3.3%).

In this study, the incidence of TRI with lidocaine (27%) is consistent with the literature where the incidence ranges up to 30 to 40%.8


    Conclusion
 TOP
 Abstract
 Methods
 Results
 Discussion
 Conclusion
 References
 
When administered in the same mg dosage, the effective duration of spinal anesthesia with procaine 10% is shorter than that obtained with lidocaine 5%. Procaine 10% does not provide a sensory or motor blockade equivalent to lidocaine 5%. Finally, procaine is associated with a higher failure rate, but the incidence of TRI is lower than with lidocaine.


    Acknowledgments
 
The authors wish to thank Mrs. Christiane Côté B.Sc. for her assistance in the data collecting for this work.

Accepted for publication January 16, 2001.


    References
 TOP
 Abstract
 Methods
 Results
 Discussion
 Conclusion
 References
 
1 Schneider M, Ettlin T, Kaufmann M, et al. Transient neurologic toxicity after hyperbaric subarachnoid anesthesia with 5% lidocaine. Anesth Analg 1993; 76: 1154–7.[Free Full Text]

2 Pollock JE, Neal JM, Stephenson CA, Wiley CE. Prospective study of the incidence of transient radicular irritation in patients undergoing spinal anesthesia. Anesthesiology 1996; 84: 1361–7.[Medline]

3 de Jong RH. Last round for a "heavyweight"? Anesth Analg 1994; 78: 3–4.[Free Full Text]

4 Bergeron L, Girard M, Drolet P, Grenier Y, Le Truong HH, Boucher C. Spinal procaine with and without epinephrine and its relation to transient radicular irritation. Can J Anesth 1999; 46: 846–9.[Abstract/Free Full Text]

5 Pinczower GR, Chadwick HS, Woodland R, Lowmiller M. Bilateral leg pain following lidocaine spinal anaesthesia. Can J Anaesth 1995; 42: 217–20.[Abstract/Free Full Text]

6 Hodgson PS, Liu SS, Batra MS, Gras TW, Pollock JE, Neal JM. Procaine compared with lidocaine for incidence of transient neurologic symptoms. Reg Anesth Pain Med 2000; 25: 218–22.[Medline]

7 Pollock JE, Liu SS, Neal JM, Stephenson CA. Dilution of spinal lidocaine does not alter the incidence of transient neurologic symptoms. Anesthesiology 1999; 90: 445–50.[Medline]

8 Hampl KF, Schneider MC, Pargger H, Gut J, Drewe J, Drasner K. A similar incidence of transient neurologic symptoms after spinal anesthesia with 2% and 5% lidocaine. Anesth Analg 1996; 83: 1051–4.[Abstract]

9 Rowlingson JC. To avoid "transient neurologic symptoms" - The search continues. Reg Anesth Pain Med 2000; 25: 215–7.[Medline]




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
D. Zaric, C. Christiansen, N. L. Pace, and Y. Punjasawadwong
Transient Neurologic Symptoms After Spinal Anesthesia with Lidocaine Versus Other Local Anesthetics: A Systematic Review of Randomized, Controlled Trials
Anesth. Analg., June 1, 2005; 100(6): 1811 - 1816.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. R. Yoos and D. J. Kopacz
Spinal 2-Chloroprocaine for Surgery: An Initial 10-Month Experience
Anesth. Analg., February 1, 2005; 100(2): 553 - 558.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
J. R. Yoos and D. J. Kopacz
Spinal 2-Chloroprocaine: A Comparison with Small-Dose Bupivacaine in Volunteers
Anesth. Analg., February 1, 2005; 100(2): 566 - 572.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
A. F. Gonter and D. J. Kopacz
Spinal 2-Chloroprocaine: A Comparison with Procaine in Volunteers
Anesth. Analg., February 1, 2005; 100(2): 573 - 579.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
M. E. Kouri and D. J. Kopacz
Spinal 2-Chloroprocaine: A Comparison with Lidocaine in Volunteers
Anesth. Analg., January 1, 2004; 98(1): 75 - 80.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
K. N. Smith, D. J. Kopacz, and S. B. McDonald
Spinal 2-Chloroprocaine: A Dose-Ranging Study and the Effect of Added Epinephrine
Anesth. Analg., January 1, 2004; 98(1): 81 - 88.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
D. T. Warren and D. J. Kopacz
Spinal 2-Chloroprocaine: The Effect of Added Dextrose
Anesth. Analg., January 1, 2004; 98(1): 95 - 101.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Résumé de cet Article
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Le Truong, H. H.
Right arrow Articles by Bergeron, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Le Truong, H. H.
Right arrow Articles by Bergeron, L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS